期刊文献+

p53、CD34与nm23在肝癌诊断及临床预后中的作用

The Significance of Expression of P53,nm23 and CD34 in the Diagnosis and Prognosis of Hepatocellular Carcinoma
下载PDF
导出
摘要 目的探讨p53、CD34和nm23基因蛋白表达在肝癌诊断及临床预后中的意义。方法用免疫组化SP法检测50例肝癌组织和55例肝非癌性增生结节p53、nm23、CD34的表达,分析它们与肝癌临床病理特征的相关性。结果p53、CD34在肝癌组织的表达比非癌组明显增高,且在肝癌组中伴有与不伴门脉瘤栓的两组间有统计学差别(P<0.05)。nm23则在非癌组中表达率高,而且nm23在癌组织中的表达与显著的瘤周淋巴细胞浸润有关(P<0.05)。不同蛋白组合联合分析生存情况发现:P53(+)、CD34(+)、nm23(-)组同其他组相比,生存时间明显为短(P<0.05)。结论p53、nm23、CD34的综合表达对肝癌有重要的辅助诊断价值,并且p53突变、CD34的高表达似乎可作为肝癌预后不良的可行性指标。 Objective To explore the significance of expre ssion of P53,nm23and CD34in the diag nosis and prognosis of hepatocellular carcin oma.Methods Immunohistochemical technique was adopted to detect the expression levels of p53,nm23and CD34in 50cases of HCC.The prognosis was analyzed accordi ng to the clinicopathological featu re indexes,which living time less than12months is considered as poor prognosis,more than12months as goodprognosis,an d used 55cases of non-neoplastic liver tissue and ben ign lesions as inner contrast.Results The expression of P53,CD34was higher in the HCC group than in the inner group,and their expression was associated with portal vein embolus(P<0.05).The expression of nm23was higher in the non-neoplastic liver tissue than in the HCC group,a nd nm23was associated with prognosis and prominent peritumoral lymphocytic infiltration(P<0.05).Combined analysis revealed that P53(+),CD34(+),nm23(-)groups had a poor prognosis than the o thers.Conclusions Detection of P53,nm23and CD34may be very useful to HCC diagnosis and prognosis.And the ove r expression of P53,CD34are considered acceptable as the parameters in p redicting of poor prognosis in HCC.
出处 《热带医学杂志》 CAS 2005年第2期227-229,199,共4页 Journal of Tropical Medicine
关键词 P53蛋白 转移抑制基因NM23 血管内皮特异性抗原CD34 肝细胞癌 诊断 预后 protein P53 nm23 CD34 hepatocellular carcinoma diagnosis prognosis
  • 相关文献

参考文献7

二级参考文献13

  • 1CW迪芬巴赫 GS德维克斯勒.PCR实验技术指南[M].北京:科技出版社,2000.11.
  • 2McGlynn KA,Rosvold EA,Lustbader ED,et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA,1995,92:2384-2387.
  • 3Guengerish FP,Johnson WW,Shimada ,et al. Activation and detoxification of aflatoxin B1. Mutat Res, 1998,402 :121-128.
  • 4Lie Cheng ,Erich M, Sturgis,et al. Glutathion-s-transferase polymorphisms and risk of squamouscellcarcinoma of the head and neck . Int J Cancer,1999,84:220-224.
  • 5Soojung Sohvy ,I. JG, NB,et al. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis.Mutation Research, 2000,460:17-28.
  • 6Wilee MGJ. Structure and function of glutathine s-transferase.Biochem Biophs Acta,1994,12:5-10 .
  • 7Fu-Sun Yeh,Mini C Yu, Chi-Chun Mo,et al. HBV,aflatoxin B1 and hepatocellular carcinoma in Southern Guanxi ,China. Cancer Res,1989,5:2506.
  • 8Ui Sun Park, Jianjia Su, Kechen Ban, et al. Mutation in p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associaated with HBV infection and intake of AFB1. Gene, 2000,251 : 72-80.
  • 9Stacy A. GSTM1 ,GSTT1 and the risk of squarmous cell carcinoma of the head and neck:A Mini -HuGE Review.Am J epidemiol, 2001,154(2) : 95-105.
  • 10Tiemersma EW,Omer RE, Bunschoten A,et al. Role of genetic polymorphism of GSTT1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma . Cancer Epidemiol-Biomarkers-Pre, 2001, 10(7) :785-791.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部